Intellectual Property News & Topics - Secerna LLP

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more

Recruitment Article 2024

News, Careers 10/09/2024

Join Secerna: Graduate Trainee Patent Attorney – Physics/Electronics

B012362

Team news, Careers 09/09/2024

Join Secerna: Graduate Trainee Patent Attorney – Life Sciences

EPO 2021

European, Industry news, News 04/09/2024

Navigating the Digital EPO: A Guide to Online Patent Filing, Management, and Collaboration

IPO Image Istock (1)

Industry news, News 02/09/2024

UK IPO Introduces Statements of Grant for International Designs

B012424

Events, News 26/08/2024

Secerna to attend Wakefield Tech & Net Zero Expo 2024

Water Tech Patents A Growing Wave Of Innovation

European, Industry news, News 20/08/2024

Water Tech Patents: A Growing Wave of Innovation

Unlocking The Value Of Intellectual Property Financing Solutions For Smes

Industry news, News 13/08/2024

The Rise of IP-Backed Financing for SMEs

Taster Day 2024 (3)

Events, News, Team news 07/08/2024

Secerna Inspires Next Generation of Patent Attorneys

IPO Image Istock

Industry news, News 01/08/2024

Standard Essential Patents Resource Hub launched by UK IPO

4 5 6 7 8 9 10 11 12 13 14